Skip to content

Insider · CIK 0001630864

Jay S. Duker

ceopresidentofficerdirector

Files at EYPT (EyePoint, Inc.). First filing Mar 16, 2026, latest Mar 16, 2026.

Jay S. Duker files SEC Form 4 as CEO, president and director at EYPT (EyePoint, Inc.). Since Mar 16, 2026, Jay S. Duker has reported 1 open-market buy worth $20k and 0 open-market sells worth $0, the latest filed on Mar 16, 2026.

A track record needs three past buys with six months of prices behind them; Jay S. Duker has 0, so none is measured yet.

The newest scored trade: bought $20k of EYPT on Mar 16, 2026, filed Mar 16, 2026, scored 29 (weak). In the last 12 months: 1 buy worth $20k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$20k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

EYPT: EyePoint, Inc.

EYPTOct 9, 2026 · close 3.40

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
29Weak
EYPTbuy
EyePoint, Inc.
$20k
1,500 shares
+2%+226% from low-29% from high

Transactions

Every row this insider has filed, 34 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 23, 2026EYPT
EyePoint, Inc.
JOther
Common Stock
-76,766$13.11$1.0M986Mar 24, 2026
Mar 23, 2026EYPT
EyePoint, Inc.
JOther
Common Stockindirect: By Family Trust
+76,766$13.11$1.0M177,431Mar 24, 2026
Mar 23, 2026EYPT
EyePoint, Inc.
JOther
Stock Option (Right to Buy)derivative
-52,500$8.75$459k7,800Mar 24, 2026
Mar 23, 2026EYPT
EyePoint, Inc.
JOther
Stock Option (Right to Buy)derivativeindirect: By Family Trust
+52,500$8.75$459k52,500Mar 24, 2026
Mar 23, 2026EYPT
EyePoint, Inc.
JOther
Stock Option (Right to Buy)derivative
-97,500$9.57$933k82,500Mar 24, 2026
Mar 23, 2026EYPT
EyePoint, Inc.
JOther
Stock Option (Right to Buy)derivativeindirect: By Family Trust
+97,500$9.57$933k97,500Mar 24, 2026
Mar 16, 2026EYPT
EyePoint, Inc.
POpen-market purchase
Common Stockindirect: By Family Trust
+1,500$13.15$20k100,665Mar 16, 2026
Jan 6, 2026EYPT
EyePoint, Inc.
MOption exercise
Common Stock
+20,793$0.00$087,806Jan 7, 2026
Jan 6, 2026EYPT
EyePoint, Inc.
FTax withholding
Common Stock
-10,054$16.86$170k77,752Jan 7, 2026
Jan 6, 2026EYPT
EyePoint, Inc.
MOption exercise
Restricted Stock Unitsderivative
-20,793$0.00$00Jan 7, 2026
Jan 3, 2026EYPT
EyePoint, Inc.
MOption exercise
Common Stock
+65,000$0.00$074,965Jan 6, 2026
Jan 3, 2026EYPT
EyePoint, Inc.
FTax withholding
Common Stock
-23,447$17.48$410k51,518Jan 6, 2026
Jan 5, 2026EYPT
EyePoint, Inc.
MOption exercise
Common Stock
+30,000$0.00$081,518Jan 6, 2026
Jan 5, 2026EYPT
EyePoint, Inc.
FTax withholding
Common Stock
-14,505$17.43$253k67,013Jan 6, 2026
Jan 2, 2026EYPT
EyePoint, Inc.
AGrant or award
Restricted Stock Unitsderivative
+165,000$0.00$0165,000Jan 6, 2026
Jan 2, 2026EYPT
EyePoint, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+331,000$0.00$0331,000Jan 6, 2026
Jan 3, 2026EYPT
EyePoint, Inc.
MOption exercise
Restricted Stock Unitsderivative
-65,000$0.00$0130,000Jan 6, 2026
Jan 5, 2026EYPT
EyePoint, Inc.
MOption exercise
Restricted Stock Unitsderivative
-30,000$0.00$030,000Jan 6, 2026
Jul 10, 2025EYPT
EyePoint, Inc.
MOption exercise
Common Stock
+16,667$0.00$017,653Jul 11, 2025
Jul 10, 2025EYPT
EyePoint, Inc.
FTax withholding
Common Stock
-7,688$11.06$85k9,965Jul 11, 2025
Jul 10, 2025EYPT
EyePoint, Inc.
MOption exercise
Restricted Stock Unitsderivative
-16,667$0.00$016,667Jul 11, 2025
Jun 23, 2025EYPT
EyePoint, Inc.
JOther
Common Stock
-56,665$8.21$465k986Jun 25, 2025
Mar 19, 2025EYPT
EyePoint, Inc.
JOther
Common Stock
-20,000$6.16$123k57,651Mar 20, 2025
Feb 9, 2025EYPT
EyePoint, Inc.
MOption exercise
Common Stock
+7,000$0.00$079,706Feb 11, 2025
Feb 9, 2025EYPT
EyePoint, Inc.
FTax withholding
Common Stock
-2,055$6.50$13k77,651Feb 11, 2025
Feb 9, 2025EYPT
EyePoint, Inc.
MOption exercise
Restricted Stock Unitsderivative
-7,000$0.00$00Feb 11, 2025
Jan 5, 2025EYPT
EyePoint, Inc.
MOption exercise
Common Stock
+30,000$0.00$068,027Jan 7, 2025
Jan 5, 2025EYPT
EyePoint, Inc.
FTax withholding
Common Stock
-10,007$8.26$83k58,020Jan 7, 2025
Jan 6, 2025EYPT
EyePoint, Inc.
MOption exercise
Common Stock
+20,794$0.00$078,814Jan 7, 2025
Jan 6, 2025EYPT
EyePoint, Inc.
FTax withholding
Common Stock
-6,108$8.68$53k72,706Jan 7, 2025
Jan 3, 2025EYPT
EyePoint, Inc.
AGrant or award
Restricted Stock Unitsderivative
+195,000$0.00$0228,334Jan 7, 2025
Jan 3, 2025EYPT
EyePoint, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+390,000$0.00$0390,000Jan 7, 2025
Jan 5, 2025EYPT
EyePoint, Inc.
MOption exercise
Restricted Stock Unitsderivative
-30,000$0.00$060,000Jan 7, 2025
Jan 6, 2025EYPT
EyePoint, Inc.
MOption exercise
Restricted Stock Unitsderivative
-20,794$0.00$039,206Jan 7, 2025

Questions about Jay S. Duker

Answered from the filings on this page, as of the latest one.

Is Jay S. Duker buying or selling?

In the last 12 months Jay S. Duker reported 1 open-market buy worth $20k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $20k of EYPT on Mar 16, 2026. Grants, option exercises and tax withholding are not counted.

How did Jay S. Duker's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jay S. Duker has 0.

Where does Jay S. Duker file Form 4?

Jay S. Duker has filed Form 4 at EYPT (EyePoint, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.